Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › FINEORG

FINEORG

Fine Organic Industries Limited
Small-capChemicals ↗

What the six lenses say about FINEORG — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹5125.0
2026-09-08
VWAP · 1Y anchor
₹4717
+8.7% from VWAP
P/E · TTM
37.7×
TTM EPS ₹136.0
52-week range
86%
position low→high
RSI(14)
50
momentum

Own sector index

Chemicals ↗
Neutral

1M

-2.7%

3M

+4.7%

1Y

—

Breadth >EMA21

40%

How FINEORG’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
5.5
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Small-cap cohortDRaw
TechnicalD688›

The actual numbers

Price vs VWAP (1y)+8.7%
EMA trend stackUp · 21>50>200
Price vs 200-EMA+7.5%
Price vs 50-EMA+1.5%
RSI(14)50
RS vs Nifty 500 · 3M+4.8%
RS vs sector · 3M+4.5%
52-week range86%
Volume vs 30d avg0.31×
Volume vs 60d avg0.46×
ATR(14) · volatility162.0
Bollinger width · vol contraction0.052
FundamentalD551›

The actual numbers

Return on equity (ROE)15.7%
Operating margin23.1%
Net margin17.6%
Revenue growth · YoY+4.4%
EPS growth · YoY+1.6%
Debt / equity0.03×

Full 8-quarter history in the financials table below.

ValuationD415›

The actual numbers

P/E (TTM)37.7×
TTM EPS₹136.0
52-week range86%
CatalystD332›

The actual numbers

Earnings & momentum28
Capital actions41
Governance32

Every filing in the corporate-announcements panel below.

FlowD550›

The actual numbers

Promoter holding75.0%
Delivery · 30d avg54.4%
Up/down-day asymmetry-0.2pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D6 + D5 ) ÷ 2 = 5.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Highest
84
Conviction score 84/100 · avg-decile strength 5.5/10
Conviction score84/100›
TechnicalD6›
FundamentalD5›
ValuationD4›
CatalystD3›
FlowD5›

Policy

Government policy · Chemicals

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Watch· MEDIUM impact

China+1 Manufacturing Shift

Supply-chain diversification away from China benefiting Indian chemical and component manufacturers

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
-0.0pp
-1.7pp
+6.2pp
+6.4pp
+22.6pp
+9.8pp
Nifty 500
Broad-market baseline
-0.1pp
-1.7pp
+5.1pp
+4.8pp
+16.8pp
+4.6pp
Sector
Own-sector index
—
—
+5.4pp
+4.5pp
+10.7pp
—

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

FINEORG daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
5125.00-27.00

Relative strength

RS vs baseline · rebased to 100

FINEORG ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
97.49-0.10

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)550596513607588597555625
↳ change QoQ—+8.4%-13.9%+18.3%-3.1%+1.5%-7.0%+12.6%
EBITDA (₹cr)16417312812012313494129
EBITDA margin29.9%29.0%25.0%19.8%20.9%22.4%16.9%20.6%
PAT (₹cr)113117839711710974117
↳ change QoQ—+3.7%-29.6%+17.3%+20.6%-6.8%-32.1%+58.1%
Net margin20.6%19.7%16.1%16.0%19.9%18.3%13.3%18.7%
EPS (₹)36.9438.3026.9731.6838.1935.4024.1138.32
D/E————————
YoY growth · Mar '26Revenue +3.0% YoYPAT +20.6% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 9 Sep '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 8 Sep '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 2 Sep '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 27 Aug '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 18 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 10 Aug '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 10 Aug '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 7 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 31 Jul '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 10 Jul '26
    MEDIUMgovernance
    Cessation
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 22 Jun '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 26 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 26 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 21 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 May '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds FINEORG

Mutual funds holding FINEORG (8)

FundWeightAUM ₹crGrade
SBI Small Cap Fund Reg Gr0.79%39,955
Axis Small Cap Fund Reg Gr1.01%30,089
Axis Flexi Cap Reg Gr1.08%13,478
ICICI Pru Pharma Healthcare Diag Gr1.18%6,803
UTI Small Cap Reg Gr0.86%5,263
Mirae Asset Small Cap Reg Gr0.75%5,221
Groww Multicap Reg Gr1.04%924
Groww Small Cap Reg Gr1.56%573

ETFs holding FINEORG (0)

No tracked ETF holds FINEORG ≥0.5%.

Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Chemicals